Methenamine Hippurate Eql Pharma

Methenamine hippurate, the active ingredient in Methenamine Hippurate Eql Pharma, is a urinary antiseptic presented as an oral dosage form for oral use. It is used to prevent recurrent urinary tract infections in adults.

GNH USA supplies Methenamine Hippurate Eql Pharma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methenamine hippurate is used in the prevention of urinary tract infections, acting as a urinary antiseptic.

- Recurrent urinary tract infections: reduces the frequency of infection in patients with a history of UTIs. - Catheter-associated prophylaxis: helps lower the risk of infection during urinary catheterization. - Neurogenic bladder management: assists in decreasing bacterial growth in patients with impaired bladder emptying.

Methenamine hippurate may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea - Vomiting - Dyspepsia - Headache - Rash - Metallic taste

Serious or Rare Side Effects: - Hematuria - Severe allergic reaction (anaphylaxis) - Stevens‑Johnson syndrome - Renal impairment - Hepatic dysfunction - Blood dyscrasias

Before prescribing methenamine hippurate, clinicians should consider several safety factors.

- Urine pH assessment: ensure acidic urine for drug activation. - Renal function: avoid in severe renal insufficiency. - Hepatic disease: use with caution in patients with liver impairment. - Allergic history: screen for hypersensitivity to methenamine or formaldehyde. - Concomitant infection: do not use as sole therapy for active UTIs. - Store at ambient temperature: keep in the original pack, protect from moisture.

Methenamine hippurate can interact with other medicines that alter urinary pH or affect renal handling.

Major Interactions (Avoid): - Alkalinizing agents (e.g., sodium bicarbonate, potassium citrate): raise urine pH and reduce drug activation. - Antacids containing magnesium or aluminum: may impair absorption.

Moderate Interactions (Monitor Closely): - Loop diuretics: increase urinary concentration of formaldehyde. - Warfarin: potential enhancement of anticoagulant effect. - Other urinary antiseptics (e.g., nitrofurantoin): overlapping antibacterial activity may increase toxicity.